These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21959256)

  • 1. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study.
    Reijmer YD; van den Berg E; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
    Atherosclerosis; 2011 Dec; 219(2):839-45. PubMed ID: 21959256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and cognition in patients with manifest atherosclerotic disease: the SMART study.
    Muller M; van Raamt F; Visseren FL; Kalmijn S; Geerlings MI; Mali WP; van der Graaf Y;
    Neuroepidemiology; 2010; 34(2):83-9. PubMed ID: 20016217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.
    Wassink AM; van der Graaf Y; Janssen KJ; Cook NR; Visseren FL;
    Eur J Prev Cardiol; 2012 Dec; 19(6):1486-95. PubMed ID: 22008749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease and cognitive performance in middle-aged and elderly men.
    Muller M; Grobbee DE; Aleman A; Bots M; van der Schouw YT
    Atherosclerosis; 2007 Jan; 190(1):143-9. PubMed ID: 16488420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of low-grade inflammation and endothelial dysfunction are related to reduced information processing speed and executive functioning in an older population - the Hoorn Study.
    Heringa SM; van den Berg E; Reijmer YD; Nijpels G; Stehouwer CD; Schalkwijk CG; Teerlink T; Scheffer PG; van den Hurk K; Kappelle LJ; Dekker JM; Biessels GJ
    Psychoneuroendocrinology; 2014 Feb; 40():108-18. PubMed ID: 24485482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study.
    Dregan A; Stewart R; Gulliford MC
    Age Ageing; 2013 May; 42(3):338-45. PubMed ID: 23179255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of combined use of three non-invasive atherosclerosis tests to predict vascular events in the elderly; carotid intima-media thickness, flow-mediated dilation of brachial artery and pulse wave velocity.
    Nagai K; Shibata S; Akishita M; Sudoh N; Obara T; Toba K; Kozaki K
    Atherosclerosis; 2013 Dec; 231(2):365-70. PubMed ID: 24267253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure and cognitive function in the general population: the Hoorn Study.
    van den Hurk K; Reijmer YD; van den Berg E; Alssema M; Nijpels G; Kostense PJ; Stehouwer CD; Paulus WJ; Kamp O; Dekker JM; Biessels GJ
    Eur J Heart Fail; 2011 Dec; 13(12):1362-9. PubMed ID: 21990341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study.
    Novo S; Peritore A; Guarneri FP; Corrado E; Macaione F; Evola S; Novo G
    Atherosclerosis; 2012 Aug; 223(2):468-72. PubMed ID: 22704563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study.
    Henry RM; Ferreira I; Dekker JM; Nijpels G; Scheffer PG; Stehouwer CD
    J Hum Hypertens; 2009 Nov; 23(11):718-27. PubMed ID: 19279658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic assessment of arterial wall structure and function in metabolic syndrome.
    Kovaite M; Petrulioniene Z; Ryliskyte L; Badariene J; Dzenkeviciute V; Cypiene A; Laucevicius A; Polena S; Gintautas J
    Proc West Pharmacol Soc; 2007; 50():123-30. PubMed ID: 18605248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression.
    Smith PJ; Blumenthal JA; Babyak MA; Hoffman BM; Doraiswamy PM; Waugh R; Hinderliter A; Sherwood A
    Psychosom Med; 2007; 69(6):578-86. PubMed ID: 17634564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia risk score predicts cognitive impairment after a period of 15 years in a nondemented population.
    Reijmer YD; van den Berg E; van Sonsbeek S; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
    Dement Geriatr Cogn Disord; 2011; 31(2):152-7. PubMed ID: 21335972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age.
    Vinkers DJ; Stek ML; van der Mast RC; de Craen AJ; Le Cessie S; Jolles J; Westendorp RG; Gussekloo J
    Neurology; 2005 Jul; 65(1):107-12. PubMed ID: 16009894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of aerobic exercise training in formerly preeclamptic women and healthy parous control subjects.
    Scholten RR; Thijssen DJ; Lotgering FK; Hopman MT; Spaanderman ME
    Am J Obstet Gynecol; 2014 Nov; 211(5):516.e1-516.e11. PubMed ID: 24769012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid atherosclerosis predicts lower cognitive test results: a 7-year follow-up study of 4,371 stroke-free subjects - the Tromsø study.
    Arntzen KA; Schirmer H; Johnsen SH; Wilsgaard T; Mathiesen EB
    Cerebrovasc Dis; 2012; 33(2):159-65. PubMed ID: 22222422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors.
    Pastori D; Loffredo L; Perri L; Baratta F; Scardella L; Polimeni L; Pani A; Brancorsini M; Albanese F; Catasca E; Del Ben M; Violi F; Angelico F
    Am J Cardiol; 2015 May; 115(10):1402-6. PubMed ID: 25776455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a cumulative effect of cardiometabolic disorders at midlife and subsequent cognitive function.
    Kesse-Guyot E; Julia C; Andreeva V; Fezeu L; Hercberg S; Galan P
    Age Ageing; 2015 Jul; 44(4):648-54. PubMed ID: 25918184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population.
    Kim NH; Park J; Kim SH; Kim YH; Kim DH; Cho GY; Baik I; Lim HE; Kim EJ; Na JO; Lee JB; Lee SK; Shin C
    Heart; 2014 Jun; 100(12):938-43. PubMed ID: 24721975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.